Histidine-Rich Glycoprotein as a Modulator of Platelet Adhesion and Aggregation: Mechanistic Insights and Clinical Implications
Posted inClinical Updates Hematology-Oncology Internal Medicine news

Histidine-Rich Glycoprotein as a Modulator of Platelet Adhesion and Aggregation: Mechanistic Insights and Clinical Implications

Histidine-rich glycoprotein (HRG) directly modulates platelet adhesion and aggregation by binding platelet receptors GPIbα and GPIIb/IIIa, competing with key ligands VWF and fibrinogen, thus attenuating thrombus formation; reduced HRG in sepsis and COVID-19 correlates with heightened platelet reactivity.
Beyond Survival: Longitudinal Health-related Quality of Life After Hepatectomy for High-risk Colorectal Liver Metastases
Posted inGeneral Surgery news Oncology

Beyond Survival: Longitudinal Health-related Quality of Life After Hepatectomy for High-risk Colorectal Liver Metastases

This prospective study reveals that health-related quality of life (HR-QoL) declines immediately after hepatectomy for high-risk colorectal liver metastases but returns to or surpasses baseline by one year in patients without recurrence, underscoring the impact of cancer recurrence on long-term quality of life.
Baseline Ischemic Burden Influences Tenecteplase Benefit Before Thrombectomy in Acute Stroke: Insights from the BRIDGE-TNK Trial
Posted inNeurology news

Baseline Ischemic Burden Influences Tenecteplase Benefit Before Thrombectomy in Acute Stroke: Insights from the BRIDGE-TNK Trial

A post hoc analysis of the BRIDGE-TNK trial reveals that intravenous tenecteplase before endovascular thrombectomy significantly improves functional independence in acute large-vessel occlusion stroke patients with extensive baseline ischemia (ASPECTS <8), while no benefit and potential risks occur in those with minor ischemia (ASPECTS 8-10).